{"protocolSection": {"identificationModule": {"nctId": "NCT01528254", "orgStudyIdInfo": {"id": "CLAF237A23156"}, "secondaryIdInfos": [{"id": "2011-003712-23", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "Novartis", "class": "INDUSTRY"}, "briefTitle": "VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-na\u00efve Patients With Type 2 Diabetes Mellitus", "officialTitle": "A 5-year Study to Compare the Durability of Glycemic Control of a Combination Regimen With Vildagliptin & Metformin Versus Standard-of-care Monotherapy With Metformin, Initiated in Treatment-na\u00efve Patients With Type 2 Diabetes Mellitus"}, "statusModule": {"statusVerifiedDate": "2020-09", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2012-03-30", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2019-04-04", "type": "ACTUAL"}, "completionDateStruct": {"date": "2019-04-04", "type": "ACTUAL"}, "studyFirstSubmitDate": "2012-02-03", "studyFirstSubmitQcDate": "2012-02-03", "studyFirstPostDateStruct": {"date": "2012-02-07", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2020-03-30", "resultsFirstSubmitQcDate": "2020-03-30", "resultsFirstPostDateStruct": {"date": "2020-04-15", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2020-09-01", "lastUpdatePostDateStruct": {"date": "2020-09-24", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Novartis Pharmaceuticals", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "The purpose of this study was to determine whether the initiation of a vildagliptin plus metformin combination regimen would result in more durable glycemic control than metformin monotherapy in treatment-na\u00efve patients with type-2 diabetes mellitus (T2DM).", "detailedDescription": "This was a multi-center, double-blind, placebo-controlled, 2-arm, parallel group study with a run-in period and up to 5 years treatment period. Following a screening visit (Visit 1) and a screening period of up to 2 weeks, treatment-na\u00efve patients, meeting all eligibility criteria entered the run-in period at Visit 2.\n\n* Run-in period: At Visit 2, in all eligible patients, metformin treatment was initiated and/or up-titrated. At the end of the 3-week run-in period, patients who were able to tolerate a total dose of at least 1000 mg and up to 2000 mg daily proceeded to randomization and started in Period 1.\n* Period 1 (vildagliptin/metformin combination versus metformin): At Visit 3, patients were randomized 1:1 to one of the following study regimens:\n\n  * Metformin up to 1000 mg bid plus vildagliptin 50mg bid or\n  * Metformin up to 1000 mg bid plus matching placebo bid\n\nThe duration of Period 1 could differ between patients depending on the time when the second of two HbA1c measurements taken at two consecutive visits after randomisation confirmed HbA1c \u2265 7.0%.\n\n\u2022 Period 2 (vildagliptin/metformin combination versus vildagliptin add-on to metformin): In the case of two consecutive HbA1c measurements \u22657.0% from two consecutive study visits during Period 1, patients who were randomised to the placebo arm in Period 1 received vildagliptin 50 mg bid. Patients who were randomised to the active vildagliptin 50 mg bid arm in Period 1 continued to receive vildagliptin 50 mg bid. All patients continued to take their metformin dose unchanged. Period 2 remained masked to the patient and both patients and investigators remained masked to the treatment allocation in Period 1.\n\nIf, during Period 2, therapy intensification was required in accordance with the local guidelines, the patient entered Period 3. The duration of Period 2 could differ between patients. End of Period 2 was considered when insulin treatment was initiated, or alternatively when the patient was discontinued because insulin treatment was not initiated in Period 3.\n\n\u2022 Period 3 (insulin initiation): In Period 3, patients were to be initiated on open-label insulin. The study drug regimen continued unchanged and remained masked to the patient in Period 3 and both patients and investigators remained masked to the treatment allocation in Period 1."}, "conditionsModule": {"conditions": ["Type 2 Diabetes Mellitus"], "keywords": ["Type 2 Diabetes Mellitus", "Vildagliptin", "Elderly Patients"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 2004, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Vilda 50mg bid + metformin", "type": "ACTIVE_COMPARATOR", "description": "Metformin + vildagliptin", "interventionNames": ["Drug: vildagliptin", "Drug: Metformin"]}, {"label": "Placebo + metformin", "type": "EXPERIMENTAL", "description": "Metformin + Placebo of vildagliptin", "interventionNames": ["Drug: Placebo of vildagliptin", "Drug: Metformin"]}], "interventions": [{"type": "DRUG", "name": "Placebo of vildagliptin", "armGroupLabels": ["Placebo + metformin"], "otherNames": ["Placebo"]}, {"type": "DRUG", "name": "vildagliptin", "description": "One tablet (50 mg oral) of vildagliptin in the morning and one tablet in the evening with or without food.", "armGroupLabels": ["Vilda 50mg bid + metformin"], "otherNames": ["LAF237"]}, {"type": "DRUG", "name": "Metformin", "description": "Twice daily (bid) regimen during or after meals at the same time as vildagliptin.", "armGroupLabels": ["Placebo + metformin", "Vilda 50mg bid + metformin"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Time to Initial Treatment Failure", "description": "Treatment failure was defined as two consecutive scheduled visits with HbA1c \\>= 7.0% (starting from 13 weeks after randomization) and the time to treatment failure was the number of days from randomization to the second of the consecutive scheduled visits.\n\nParticipants who discontinued the study for any reason during Period 1 were censored at the date of discontinuation. Participants who remained under the threshold (or whose measurement above the threshold was not confirmed at next scheduled visit) were censored at the date of last study visit.", "timeFrame": "Visit 4 (Week 13) up to End of Study (Study Drug Discontinuation or Premature Subject Discontinuation)"}], "secondaryOutcomes": [{"measure": "Rate of Loss in Glycemic Control During Period 1", "description": "The rate of loss in glycemic control was estimated using the slope of HbA1c over time (years).\n\nHbA1c data collected from Week 26 up to and including the end of Period 1 visit was included in the analysis. Baseline HbA1c was the sample obtained on day 1, or the sample obtained at an earlier visit (scheduled or unscheduled) which was closest to Day 1, if the Day 1 measurement was missing. End of Period 1 was defined as the final post-baseline assessment obtained at any visit within Period 1 (scheduled or unscheduled), up to the last scheduled visit.", "timeFrame": "Visit 5 (Week 26) to End of Period 1"}, {"measure": "Rate of Loss in Glycemic Control in HbA1c Over Time During Period 2", "description": "The rate of loss in glycemic control was estimated using the slope of HbA1c over time (years).\n\nHbA1c data collected from 26 weeks after the start of Period 2 to the end of Period 2 were included in the analysis, for participants who started insulin therapy in Period 3 or discontinued during Period 2 due to being unable or unwilling to initiate insulin therapy in period 3. Participants who completed the study in Period 1 or Period 2 were not be included in the analysis.", "timeFrame": "From 26 weeks after start of Period 2 to end of Period 2"}, {"measure": "Rate of Loss in Glycemic Control in Fasting Plasma Glucose (FPG) During Period 1", "description": "Rate of loss in glycemic control was estimated using the slope of FPG over time (years).\n\nFPG (fasting plasma glucose) data from Week 26 to the end of Period 1 was included in the analysis. Baseline FPG was the sample obtained on day 1, or the sample obtained at an earlier visit (scheduled or unscheduled) which was closest to Day 1, if the Day 1 measurement is missing. Participants who completed the study in Period 1 or Period 2 were not be included in the analysis.", "timeFrame": "Visit 5 (Week 26) to End of Period 1"}, {"measure": "Rate of Loss in Glycemic Control in Fasting Plasma Glucose (FPG) Over Time During Period 2", "description": "Rate of loss in glycemic control was estimated using the slope of FPG over time (years).\n\nFPG (fasting plasma glucose) data from 26 weeks after the start of Period 2 to then end of Period 2 was included in the analysis. Only participants who started insulin therapy in Period 3 or discontinued during Period 2 due to being unable or unwilling to initiate insulin therapy in period 3 were included. Participants who completed the study in Period 1 or Period 2 were not be included in the analysis.", "timeFrame": "From 26 weeks after start of Period 2 to end of Period 2"}, {"measure": "Rate of Loss of Beta Cell Function From Baseline to End of Study", "description": "The rate of change of beta cell function was assessed using the slope of AUC of ISR/G over time (years) where AUC of ISR/G is defined as (Area under curve of Insulin secretion rate (derived using c-peptide))/(Area under curve of Glucose), using meal-test data from 0 to 120 minutes. Baseline AUC of ISR/G was derived based on samples obtained on day 1, or samples obtained at an earlier visit (scheduled or unscheduled) which was closest to Day 1, if the Day 1 measurements were missing. Three analyses were included, using data from Week 13 to the end of Period 1, end of Period 2 and end of study, respectively.", "timeFrame": "Visit 4 (Week 13), End of Period 1, End of Period 2, End of Study (Study Drug Discontinuation or Premature Subject Discontinuation)"}, {"measure": "Rate of Change in Insulin Sensitivity From Baseline to End of Study", "description": "The rate of change of insulin sensitivity is assessed using the slope of OGIS over time (years) where Oral glucose insulin sensitivity (OGIS) was calculated as a function of glucose and insulin, using meal-test data from 0 to 120 minutes. Baseline OGIS is derived based on samples obtained on day 1, or samples obtained at an earlier visit (scheduled or unscheduled) which was closest to Day 1, if the Day 1 measurements are missing. Three analyses were included, using data from Week 13 to the end of Period 1, end of Period 2 and end of study, respectively.", "timeFrame": "Visit 4 (Week 13), End of Period 1, End of Period 2, End of Study (Study Drug Discontinuation or Premature Subject Discontinuation)"}, {"measure": "Percentage of Participants With Adverse Events, Serious Adverse Events and Death", "description": "Analysis of absolute and relative frequencies for treatment emergent Adverse Event (AE), Serious Adverse Event (SAE) and Deaths by primary System Organ Class (SOC) in each treatment arm to demonstrate that LAF237 is safe for the treatment of na\u00efve patients with type 2 diabetes mellitus through the monitoring of relevant clinical and laboratory safety parameters.", "timeFrame": "From first dose of study treatment until End of Study (Study Drug Discontinuation or Premature Subject Discontinuation)"}]}, "eligibilityModule": {"eligibilityCriteria": "Key Inclusion Criteria:\n\n* Type 2 Diabetes Mellitus (T2DM) diagnosed \u2264 24 months ago\n* glycosylated hemoglobin (HbA1c) \u22656.5% and \u22647.5% at Visit 1\n* Treatment-na\u00efve.\n* Body mass index (BMI) \u226522 and \u226440 kg/m2 at Visit 1\n\nKey Exclusion Criteria:\n\n* Pregnant or nursing (lactating) women\n* Fasting plasma glucose (FPG) \u2265 270 mg/dL (\u2265 15.0 mmol/L)\n* Previous or current participation in any vildagliptin clinical study.\n* History of hypersensitivity to dipeptidyl peptidase-4 (DPP-4) inhibitors.\n* Concurrent medical condition that may interfere with the interpretation of efficacy and safety data during the study.\n* Donation of blood or significant blood loss equaling to at least one unit of blood within the past 2 weeks of start of study or a blood transfusion within the past 12 weeks or planned regular transfusions during the study period.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "70 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Novartis Pharmaceuticals", "affiliation": "Novartis Pharmaceuticals", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1056ABJ", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Buenos Aires", "zip": "C1425AGC", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "San Isidro", "state": "Buenos Aires", "zip": "1642", "country": "Argentina", "geoPoint": {"lat": -34.4721, "lon": -58.52708}}, {"facility": "Novartis Investigative Site", "city": "Caba", "state": "Capital Federal", "zip": "C1179AAB", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Buenos Aires", "zip": "C1120AAC", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "Novartis Investigative Site", "city": "Cordoba", "zip": "X5000AAW", "country": "Argentina", "geoPoint": {"lat": -31.4135, "lon": -64.18105}}, {"facility": "Novartis Investigative Site", "city": "Corrientes", "zip": "3400", "country": "Argentina", "geoPoint": {"lat": -27.4806, "lon": -58.8341}}, {"facility": "Novartis Investigative Site", "city": "Brookvale", "state": "New South Wales", "zip": "2100", "country": "Australia", "geoPoint": {"lat": -33.76108, "lon": 151.27446}}, {"facility": "Novartis Investigative Site", "city": "Woy Woy", "state": "New South Wales", "zip": "2256", "country": "Australia", "geoPoint": {"lat": -33.48433, "lon": 151.32471}}, {"facility": "Novartis Investigative Site", "city": "Morayfield", "state": "Queensland", "zip": "4506", "country": "Australia", "geoPoint": {"lat": -27.10876, "lon": 152.94907}}, {"facility": "Novartis Investigative Site", "city": "Wien", "zip": "A-1130", "country": "Austria", "geoPoint": {"lat": 48.20849, "lon": 16.37208}}, {"facility": "Novartis Investigative Site", "city": "Fortaleza", "state": "CE", "zip": "60170-320", "country": "Brazil", "geoPoint": {"lat": -3.71722, "lon": -38.54306}}, {"facility": "Novartis Investigative Site", "city": "Fortaleza", "state": "CE", "zip": "60430-350", "country": "Brazil", "geoPoint": {"lat": -3.71722, "lon": -38.54306}}, {"facility": "Novartis Investigative Site", "city": "Brasilia", "state": "DF", "zip": "71625-009", "country": "Brazil", "geoPoint": {"lat": -15.77972, "lon": -47.92972}}, {"facility": "Novartis Investigative Site", "city": "Goiania", "state": "GO", "zip": "74935-530", "country": "Brazil", "geoPoint": {"lat": -16.67861, "lon": -49.25389}}, {"facility": "Novartis Investigative Site", "city": "Belem", "state": "PA", "zip": "66073-000", "country": "Brazil", "geoPoint": {"lat": -1.45583, "lon": -48.50444}}, {"facility": "Novartis Investigative Site", "city": "Curitiba", "state": "PR", "zip": "80810-040", "country": "Brazil", "geoPoint": {"lat": -25.42778, "lon": -49.27306}}, {"facility": "Novartis Investigative Site", "city": "Porto Alegre", "state": "RS", "zip": "90430 001", "country": "Brazil", "geoPoint": {"lat": -30.03306, "lon": -51.23}}, {"facility": "Novartis Investigative Site", "city": "Mogi das Cruzes", "state": "SP", "zip": "08780-090", "country": "Brazil", "geoPoint": {"lat": -23.52278, "lon": -46.18833}}, {"facility": "Novartis Investigative Site", "city": "Sao Paulo", "state": "SP", "zip": "04023-900", "country": "Brazil", "geoPoint": {"lat": -23.5475, "lon": -46.63611}}, {"facility": "Novartis Investigative Site", "city": "Sao Paulo", "state": "SP", "zip": "05403 000", "country": "Brazil", "geoPoint": {"lat": -23.5475, "lon": -46.63611}}, {"facility": "Novartis Investigative Site", "city": "S\u00e3o Paulo", "state": "SP", "zip": "01224-000", "country": "Brazil", "geoPoint": {"lat": -23.5475, "lon": -46.63611}}, {"facility": "Novartis Investigative Site", "city": "S\u00e3o Paulo", "state": "SP", "zip": "01244-030", "country": "Brazil", "geoPoint": {"lat": -23.5475, "lon": -46.63611}}, {"facility": "Novartis Investigative Site", "city": "Gabrovo", "zip": "5300", "country": "Bulgaria", "geoPoint": {"lat": 42.87472, "lon": 25.33417}}, {"facility": "Novartis Investigative Site", "city": "Kazanlak", "zip": "6100", "country": "Bulgaria", "geoPoint": {"lat": 42.61667, "lon": 25.4}}, {"facility": "Novartis Investigative Site", "city": "Plovdiv", "zip": "4002", "country": "Bulgaria", "geoPoint": {"lat": 42.15, "lon": 24.75}}, {"facility": "Novartis Investigative Site", "city": "Razgrad", "country": "Bulgaria", "geoPoint": {"lat": 43.53333, "lon": 26.51667}}, {"facility": "Novartis Investigative Site", "city": "Ruse", "zip": "7200", "country": "Bulgaria", "geoPoint": {"lat": 43.85639, "lon": 25.97083}}, {"facility": "Novartis Investigative Site", "city": "Smolian", "zip": "4700", "country": "Bulgaria"}, {"facility": "Novartis Investigative Site", "city": "Sofia", "zip": "1431", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"facility": "Novartis Investigative Site", "city": "Sofia", "zip": "1606", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"facility": "Novartis Investigative Site", "city": "Sofia", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"facility": "Novartis Investigative Site", "city": "Cartagena", "state": "Bolivar", "country": "Colombia", "geoPoint": {"lat": 10.39972, "lon": -75.51444}}, {"facility": "Novartis Investigative Site", "city": "Bogota", "state": "Cundinamarca", "zip": "110221", "country": "Colombia", "geoPoint": {"lat": 4.60971, "lon": -74.08175}}, {"facility": "Novartis Investigative Site", "city": "Baranquilla", "country": "Colombia"}, {"facility": "Novartis Investigative Site", "city": "Bogot\u00e1", "country": "Colombia", "geoPoint": {"lat": 4.60971, "lon": -74.08175}}, {"facility": "Novartis Investigative Site", "city": "Pisek", "state": "Czech Republic", "zip": "397 01", "country": "Czechia", "geoPoint": {"lat": 49.3088, "lon": 14.1475}}, {"facility": "Novartis Investigative Site", "city": "Prague 5", "state": "Czech Republic", "zip": "150 30", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Novartis Investigative Site", "city": "Brandys Nad Labem", "zip": "250 01", "country": "Czechia", "geoPoint": {"lat": 50.18356, "lon": 14.67244}}, {"facility": "Novartis Investigative Site", "city": "Praha", "zip": "149 01", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Novartis Investigative Site", "city": "Santo Domingo", "state": "Republica Dominicana", "country": "Dominican Republic", "geoPoint": {"lat": 18.50012, "lon": -69.98857}}, {"facility": "Novartis Investigative Site", "city": "Santo Domingo", "country": "Dominican Republic", "geoPoint": {"lat": 18.50012, "lon": -69.98857}}, {"facility": "Novartis Investigative Site", "city": "Saku", "zip": "75501", "country": "Estonia", "geoPoint": {"lat": 59.30351, "lon": 24.66369}}, {"facility": "Novartis Investigative Site", "city": "Tallinn", "zip": "10117", "country": "Estonia", "geoPoint": {"lat": 59.43696, "lon": 24.75353}}, {"facility": "Novartis Investigative Site", "city": "Tallinn", "zip": "11315", "country": "Estonia", "geoPoint": {"lat": 59.43696, "lon": 24.75353}}, {"facility": "Novartis Investigative Site", "city": "Tallinn", "zip": "11911", "country": "Estonia", "geoPoint": {"lat": 59.43696, "lon": 24.75353}}, {"facility": "Novartis Investigative Site", "city": "Tallinn", "zip": "13415", "country": "Estonia", "geoPoint": {"lat": 59.43696, "lon": 24.75353}}, {"facility": "Novartis Investigative Site", "city": "Lahti", "state": "Suomi", "zip": "15110", "country": "Finland", "geoPoint": {"lat": 60.98267, "lon": 25.66151}}, {"facility": "Novartis Investigative Site", "city": "Kerava", "zip": "04200", "country": "Finland", "geoPoint": {"lat": 60.40338, "lon": 25.105}}, {"facility": "Novartis Investigative Site", "city": "Kouvola", "zip": "45100", "country": "Finland", "geoPoint": {"lat": 60.86667, "lon": 26.7}}, {"facility": "Novartis Investigative Site", "city": "Tampere", "zip": "33100", "country": "Finland", "geoPoint": {"lat": 61.49911, "lon": 23.78712}}, {"facility": "Novartis Investigative Site", "city": "Hainstadt", "state": "Hainburg", "zip": "63512", "country": "Germany"}, {"facility": "Novartis Investigative Site", "city": "Aschaffenburg", "zip": "63739", "country": "Germany", "geoPoint": {"lat": 49.97704, "lon": 9.15214}}, {"facility": "Novartis Investigative Site", "city": "Dresden", "zip": "01307", "country": "Germany", "geoPoint": {"lat": 51.05089, "lon": 13.73832}}, {"facility": "Novartis Investigative Site", "city": "Duesseldorf", "zip": "40225", "country": "Germany", "geoPoint": {"lat": 51.22172, "lon": 6.77616}}, {"facility": "Novartis Investigative Site", "city": "Essen", "zip": "45276", "country": "Germany", "geoPoint": {"lat": 51.45657, "lon": 7.01228}}, {"facility": "Novartis Investigative Site", "city": "Essen", "zip": "45329", "country": "Germany", "geoPoint": {"lat": 51.45657, "lon": 7.01228}}, {"facility": "Novartis Investigative Site", "city": "Esslingen am Neckar", "zip": "73728", "country": "Germany", "geoPoint": {"lat": 48.73961, "lon": 9.30473}}, {"facility": "Novartis Investigative Site", "city": "Fulda", "zip": "36037", "country": "Germany", "geoPoint": {"lat": 50.55162, "lon": 9.67518}}, {"facility": "Novartis Investigative Site", "city": "Gelnhausen", "zip": "63571", "country": "Germany", "geoPoint": {"lat": 50.20164, "lon": 9.18742}}, {"facility": "Novartis Investigative Site", "city": "Kamp-Lintfort", "zip": "47475", "country": "Germany", "geoPoint": {"lat": 51.50467, "lon": 6.54587}}, {"facility": "Novartis Investigative Site", "city": "Koeln", "zip": "51069", "country": "Germany", "geoPoint": {"lat": 50.93333, "lon": 6.95}}, {"facility": "Novartis Investigative Site", "city": "Ludwigshafen", "zip": "67059", "country": "Germany", "geoPoint": {"lat": 49.48121, "lon": 8.44641}}, {"facility": "Novartis Investigative Site", "city": "Neuwied", "zip": "56564", "country": "Germany", "geoPoint": {"lat": 50.4336, "lon": 7.47057}}, {"facility": "Novartis Investigative Site", "city": "Saint Ingbert - Oberwuerzbach", "zip": "66386", "country": "Germany"}, {"facility": "Novartis Investigative Site", "city": "Wangen", "zip": "88239", "country": "Germany", "geoPoint": {"lat": 48.72933, "lon": 9.61175}}, {"facility": "Novartis Investigative Site", "city": "Clinica", "zip": "605", "country": "Guatemala"}, {"facility": "Novartis Investigative Site", "city": "Guatemala City", "zip": "010014", "country": "Guatemala", "geoPoint": {"lat": 14.64072, "lon": -90.51327}}, {"facility": "Novartis Investigative Site", "city": "Guatemala City", "zip": "01010", "country": "Guatemala", "geoPoint": {"lat": 14.64072, "lon": -90.51327}}, {"facility": "Novartis Investigative Site", "city": "Hong Kong", "country": "Hong Kong", "geoPoint": {"lat": 22.27832, "lon": 114.17469}}, {"facility": "Novartis Investigative Site", "city": "HongKong", "country": "Hong Kong", "geoPoint": {"lat": 22.27832, "lon": 114.17469}}, {"facility": "Novartis Investigative Site", "city": "Zalaegerszeg", "state": "Zala", "zip": "8900", "country": "Hungary", "geoPoint": {"lat": 46.84, "lon": 16.84389}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "zip": "1042", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Budapest", "zip": "1212", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Novartis Investigative Site", "city": "Csongrad", "zip": "6640", "country": "Hungary", "geoPoint": {"lat": 46.71332, "lon": 20.14241}}, {"facility": "Novartis Investigative Site", "city": "Eger", "zip": "H-3300", "country": "Hungary", "geoPoint": {"lat": 47.90265, "lon": 20.37329}}, {"facility": "Novartis Investigative Site", "city": "Kalocsa", "zip": "6300", "country": "Hungary", "geoPoint": {"lat": 46.52639, "lon": 18.98583}}, {"facility": "Novartis Investigative Site", "city": "Szeged", "zip": "H 6725", "country": "Hungary", "geoPoint": {"lat": 46.253, "lon": 20.14824}}, {"facility": "Novartis Investigative Site", "city": "Veszprem", "zip": "H 8200", "country": "Hungary", "geoPoint": {"lat": 47.09327, "lon": 17.91149}}, {"facility": "Novartis Investigative Site", "city": "New Delhi", "state": "Delhi", "zip": "110076", "country": "India", "geoPoint": {"lat": 28.63576, "lon": 77.22445}}, {"facility": "Novartis Investigative Site", "city": "Bangalore", "state": "Karnataka", "zip": "560003", "country": "India", "geoPoint": {"lat": 12.97194, "lon": 77.59369}}, {"facility": "Novartis Investigative Site", "city": "Bangalore", "state": "Karnataka", "zip": "560034", "country": "India", "geoPoint": {"lat": 12.97194, "lon": 77.59369}}, {"facility": "Novartis Investigative Site", "city": "Bangalore", "state": "Karnataka", "zip": "560043", "country": "India", "geoPoint": {"lat": 12.97194, "lon": 77.59369}}, {"facility": "Novartis Investigative Site", "city": "Kochi", "state": "Kerala", "zip": "682 041", "country": "India", "geoPoint": {"lat": 9.93988, "lon": 76.26022}}, {"facility": "Novartis Investigative Site", "city": "Indore", "state": "Madhya Pradesh", "zip": "452010", "country": "India", "geoPoint": {"lat": 22.71792, "lon": 75.8333}}, {"facility": "Novartis Investigative Site", "city": "Pune", "state": "Maharashtra", "zip": "411004", "country": "India", "geoPoint": {"lat": 18.51957, "lon": 73.85535}}, {"facility": "Novartis Investigative Site", "city": "Pune", "state": "Maharashtra", "zip": "411011", "country": "India", "geoPoint": {"lat": 18.51957, "lon": 73.85535}}, {"facility": "Novartis Investigative Site", "city": "Jaipur", "state": "Rajasthan", "zip": "302015", "country": "India", "geoPoint": {"lat": 26.91962, "lon": 75.78781}}, {"facility": "Novartis Investigative Site", "city": "Jaipur", "state": "Rajasthan", "zip": "302023", "country": "India", "geoPoint": {"lat": 26.91962, "lon": 75.78781}}, {"facility": "Novartis Investigative Site", "city": "Chennai", "state": "Tamil Nadu", "zip": "600 086", "country": "India", "geoPoint": {"lat": 13.08784, "lon": 80.27847}}, {"facility": "Novartis Investigative Site", "city": "Chennai", "state": "Tamilnadu", "zip": "600008", "country": "India", "geoPoint": {"lat": 13.08784, "lon": 80.27847}}, {"facility": "Novartis Investigative Site", "city": "Chandigarh", "zip": "160 012", "country": "India", "geoPoint": {"lat": 30.73629, "lon": 76.7884}}, {"facility": "Novartis Investigative Site", "city": "Heifa", "country": "Israel"}, {"facility": "Novartis Investigative Site", "city": "Jerusalem", "zip": "91192", "country": "Israel", "geoPoint": {"lat": 31.76904, "lon": 35.21633}}, {"facility": "Novartis Investigative Site", "city": "Kfar Saba", "zip": "4428164", "country": "Israel", "geoPoint": {"lat": 32.175, "lon": 34.90694}}, {"facility": "Novartis Investigative Site", "city": "Rehovot", "zip": "7610001", "country": "Israel", "geoPoint": {"lat": 31.89421, "lon": 34.81199}}, {"facility": "Novartis Investigative Site", "city": "Sefad", "zip": "13100", "country": "Israel"}, {"facility": "Novartis Investigative Site", "city": "Tel Aviv", "zip": "6209804", "country": "Israel", "geoPoint": {"lat": 32.08088, "lon": 34.78057}}, {"facility": "Novartis Investigative Site", "city": "Tel Giborim, Holon", "zip": "58100", "country": "Israel"}, {"facility": "Novartis Investigative Site", "city": "Montichiari", "state": "BS", "zip": "25018", "country": "Italy", "geoPoint": {"lat": 45.41317, "lon": 10.39799}}, {"facility": "Novartis Investigative Site", "city": "Campobasso", "state": "CB", "zip": "86100", "country": "Italy", "geoPoint": {"lat": 41.55947, "lon": 14.66737}}, {"facility": "Novartis Investigative Site", "city": "Arenzano", "state": "GE", "zip": "16011", "country": "Italy", "geoPoint": {"lat": 44.40521, "lon": 8.68315}}, {"facility": "Novartis Investigative Site", "city": "Milano", "state": "MI", "zip": "20100", "country": "Italy", "geoPoint": {"lat": 45.46427, "lon": 9.18951}}, {"facility": "Novartis Investigative Site", "city": "Milano", "state": "MI", "zip": "20132", "country": "Italy", "geoPoint": {"lat": 45.46427, "lon": 9.18951}}, {"facility": "Novartis Investigative Site", "city": "Casorate Primo", "state": "PV", "zip": "27022", "country": "Italy", "geoPoint": {"lat": 45.31142, "lon": 9.01703}}, {"facility": "Novartis Investigative Site", "city": "Roma", "state": "RM", "zip": "00133", "country": "Italy", "geoPoint": {"lat": 41.89193, "lon": 12.51133}}, {"facility": "Novartis Investigative Site", "city": "Roma", "state": "RM", "zip": "00161", "country": "Italy", "geoPoint": {"lat": 41.89193, "lon": 12.51133}}, {"facility": "Novartis Investigative Site", "city": "Incheon", "state": "Gyeonggi-do", "zip": "21431", "country": "Korea, Republic of", "geoPoint": {"lat": 37.45646, "lon": 126.70515}}, {"facility": "Novartis Investigative Site", "city": "Suwon", "state": "Gyeonggi-do", "zip": "442-723", "country": "Korea, Republic of", "geoPoint": {"lat": 37.29111, "lon": 127.00889}}, {"facility": "Novartis Investigative Site", "city": "Uijeongbu-Si", "state": "Gyeonggi-do", "zip": "480-717", "country": "Korea, Republic of", "geoPoint": {"lat": 37.7415, "lon": 127.0474}}, {"facility": "Novartis Investigative Site", "city": "Seoul", "state": "Korea", "zip": "03312", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"facility": "Novartis Investigative Site", "city": "Seoul", "state": "Seocho Gu", "zip": "06591", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"facility": "Novartis Investigative Site", "city": "Daejeon", "zip": "301-804", "country": "Korea, Republic of", "geoPoint": {"lat": 36.32139, "lon": 127.41972}}, {"facility": "Novartis Investigative Site", "city": "Incheon", "zip": "403-720", "country": "Korea, Republic of", "geoPoint": {"lat": 37.45646, "lon": 126.70515}}, {"facility": "Novartis Investigative Site", "city": "Seoul", "zip": "150-713", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"facility": "Novartis Investigative Site", "city": "Jelgava", "state": "LV", "zip": "3001", "country": "Latvia", "geoPoint": {"lat": 56.65, "lon": 23.71278}}, {"facility": "Novartis Investigative Site", "city": "Liepaja", "state": "LV", "zip": "3401", "country": "Latvia", "geoPoint": {"lat": 56.51667, "lon": 21.01667}}, {"facility": "Novartis Investigative Site", "city": "Ogre", "state": "LV", "zip": "5001", "country": "Latvia", "geoPoint": {"lat": 56.8162, "lon": 24.61401}}, {"facility": "Novartis Investigative Site", "city": "Riga", "state": "LV", "zip": "1002", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "Novartis Investigative Site", "city": "Riga", "state": "LV", "zip": "1011", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "Novartis Investigative Site", "city": "Talsi", "state": "LV", "zip": "3201", "country": "Latvia", "geoPoint": {"lat": 57.24562, "lon": 22.58137}}, {"facility": "Novartis Investigative Site", "city": "Daugavpils", "zip": "LV-5417", "country": "Latvia", "geoPoint": {"lat": 55.88333, "lon": 26.53333}}, {"facility": "Novartis Investigative Site", "city": "Riga", "zip": "1057", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "Novartis Investigative Site", "city": "Riga", "zip": "LV 1002", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "Novartis Investigative Site", "city": "Kaunas", "state": "LTU", "zip": "LT 50161", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"facility": "Novartis Investigative Site", "city": "Vilnius", "state": "LT", "country": "Lithuania", "geoPoint": {"lat": 54.68916, "lon": 25.2798}}, {"facility": "Novartis Investigative Site", "city": "Jonava", "zip": "55268", "country": "Lithuania", "geoPoint": {"lat": 55.08333, "lon": 24.28333}}, {"facility": "Novartis Investigative Site", "city": "Kaunas", "zip": "48259", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"facility": "Novartis Investigative Site", "city": "Kaunas", "zip": "51270", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"facility": "Novartis Investigative Site", "city": "Vilnius", "zip": "LT-08661", "country": "Lithuania", "geoPoint": {"lat": 54.68916, "lon": 25.2798}}, {"facility": "Novartis Investigative Site", "city": "Kota Bahru", "state": "Kelantan", "zip": "16150", "country": "Malaysia", "geoPoint": {"lat": 6.13328, "lon": 102.2386}}, {"facility": "Novartis Investigative Site", "city": "Kuala Lumpur", "zip": "56000", "country": "Malaysia", "geoPoint": {"lat": 3.1412, "lon": 101.68653}}, {"facility": "Novartis Investigative Site", "city": "Kuala Lumpur", "zip": "59100", "country": "Malaysia", "geoPoint": {"lat": 3.1412, "lon": 101.68653}}, {"facility": "Novartis Investigative Site", "city": "Ciudad De Mexico", "state": "Distrito Federal", "zip": "11850", "country": "Mexico", "geoPoint": {"lat": 19.42847, "lon": -99.12766}}, {"facility": "Novartis Investigative Site", "city": "Mexico D.F", "state": "Distrito Federal", "zip": "03100", "country": "Mexico"}, {"facility": "Novartis Investigative Site", "city": "M\u00e9xico", "state": "Distrito Federal", "zip": "03800", "country": "Mexico", "geoPoint": {"lat": 19.42847, "lon": -99.12766}}, {"facility": "Novartis Investigative Site", "city": "Cuautla", "state": "Morelos", "zip": "62746", "country": "Mexico", "geoPoint": {"lat": 18.8106, "lon": -98.93525}}, {"facility": "Novartis Investigative Site", "city": "Cuernavaca", "state": "Morelos", "zip": "62250", "country": "Mexico", "geoPoint": {"lat": 18.9261, "lon": -99.23075}}, {"facility": "Novartis Investigative Site", "city": "Aguascalientes", "zip": "20230", "country": "Mexico", "geoPoint": {"lat": 21.88234, "lon": -102.28259}}, {"facility": "Novartis Investigative Site", "city": "Distrito Federal", "zip": "14000", "country": "Mexico", "geoPoint": {"lat": 16.59, "lon": -93.02694}}, {"facility": "Novartis Investigative Site", "city": "Durango", "zip": "34000", "country": "Mexico", "geoPoint": {"lat": 24.02032, "lon": -104.65756}}, {"facility": "Novartis Investigative Site", "city": "Quer\u00e9taro", "zip": "76000", "country": "Mexico"}, {"facility": "Novartis Investigative Site", "city": "Enebakk", "zip": "1912", "country": "Norway"}, {"facility": "Novartis Investigative Site", "city": "Fetsund", "zip": "1900", "country": "Norway", "geoPoint": {"lat": 59.92463, "lon": 11.15711}}, {"facility": "Novartis Investigative Site", "city": "Honefoss", "zip": "3515", "country": "Norway", "geoPoint": {"lat": 60.16804, "lon": 10.25647}}, {"facility": "Novartis Investigative Site", "city": "Oslo", "zip": "0424", "country": "Norway", "geoPoint": {"lat": 59.91273, "lon": 10.74609}}, {"facility": "Novartis Investigative Site", "city": "Spikkestad", "zip": "3430", "country": "Norway", "geoPoint": {"lat": 59.74396, "lon": 10.33698}}, {"facility": "Novartis Investigative Site", "city": "Panama City", "zip": "0834-01862", "country": "Panama", "geoPoint": {"lat": 8.9936, "lon": -79.51973}}, {"facility": "Novartis Investigative Site", "city": "Panama City", "country": "Panama", "geoPoint": {"lat": 8.9936, "lon": -79.51973}}, {"facility": "Novartis Investigative Site", "city": "Trujillo", "state": "La Libertad", "country": "Peru", "geoPoint": {"lat": -8.11599, "lon": -79.02998}}, {"facility": "Novartis Investigative Site", "city": "Cercado De Lima", "state": "Lima", "zip": "01", "country": "Peru"}, {"facility": "Novartis Investigative Site", "city": "Chorrillos", "state": "Lima", "zip": "09", "country": "Peru"}, {"facility": "Novartis Investigative Site", "city": "Magdalena", "state": "Lima", "zip": "17", "country": "Peru"}, {"facility": "Novartis Investigative Site", "city": "San Isidro", "state": "Lima", "zip": "27", "country": "Peru", "geoPoint": {"lat": -12.11667, "lon": -77.05}}, {"facility": "Novartis Investigative Site", "city": "San Martin de Porres", "state": "Lima", "zip": "31", "country": "Peru"}, {"facility": "Novartis Investigative Site", "city": "Arequipa", "country": "Peru", "geoPoint": {"lat": -16.39889, "lon": -71.535}}, {"facility": "Novartis Investigative Site", "city": "Marikina", "state": "Metro Manila", "zip": "1810", "country": "Philippines"}, {"facility": "Novartis Investigative Site", "city": "Quezon City", "state": "Metro Manila", "zip": "1109", "country": "Philippines", "geoPoint": {"lat": 14.6488, "lon": 121.0509}}, {"facility": "Novartis Investigative Site", "city": "Marikina City", "zip": "1800", "country": "Philippines", "geoPoint": {"lat": 14.6481, "lon": 121.1133}}, {"facility": "Novartis Investigative Site", "city": "Pasay City", "zip": "1300", "country": "Philippines"}, {"facility": "Novartis Investigative Site", "city": "Pasig City", "zip": "1600", "country": "Philippines", "geoPoint": {"lat": 14.58691, "lon": 121.0614}}, {"facility": "Novartis Investigative Site", "city": "San Juan City", "zip": "1500", "country": "Philippines", "geoPoint": {"lat": 14.6, "lon": 121.0333}}, {"facility": "Novartis Investigative Site", "city": "Poznan", "zip": "60-821", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"facility": "Novartis Investigative Site", "city": "Poznan", "zip": "61-251", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"facility": "Novartis Investigative Site", "city": "Poznan", "zip": "61-655", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"facility": "Novartis Investigative Site", "city": "Wroclaw", "zip": "50-349", "country": "Poland", "geoPoint": {"lat": 51.1, "lon": 17.03333}}, {"facility": "Novartis Investigative Site", "city": "Zabrze", "zip": "41-800", "country": "Poland", "geoPoint": {"lat": 50.32492, "lon": 18.78576}}, {"facility": "Novartis Investigative Site", "city": "Oradea", "state": "Bihor", "zip": "410001", "country": "Romania", "geoPoint": {"lat": 47.0458, "lon": 21.91833}}, {"facility": "Novartis Investigative Site", "city": "Oradea", "state": "Jud. Bihor", "zip": "410619", "country": "Romania", "geoPoint": {"lat": 47.0458, "lon": 21.91833}}, {"facility": "Novartis Investigative Site", "city": "Ploiesti", "state": "Jud. Prahova", "zip": "100097", "country": "Romania", "geoPoint": {"lat": 44.95, "lon": 26.01667}}, {"facility": "Novartis Investigative Site", "city": "Bucharest", "zip": "020045", "country": "Romania", "geoPoint": {"lat": 44.43225, "lon": 26.10626}}, {"facility": "Novartis Investigative Site", "city": "Bucharest", "zip": "020475", "country": "Romania", "geoPoint": {"lat": 44.43225, "lon": 26.10626}}, {"facility": "Novartis Investigative Site", "city": "Bucuresti", "country": "Romania", "geoPoint": {"lat": 44.42802, "lon": 26.09665}}, {"facility": "Novartis Investigative Site", "city": "Timisoara", "country": "Romania", "geoPoint": {"lat": 45.75372, "lon": 21.22571}}, {"facility": "Novartis Investigative Site", "city": "Moscow", "zip": "101990", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "Novartis Investigative Site", "city": "N.Novgorod", "zip": "603126", "country": "Russian Federation"}, {"facility": "Novartis Investigative Site", "city": "Penza", "zip": "440026", "country": "Russian Federation", "geoPoint": {"lat": 53.20066, "lon": 45.00464}}, {"facility": "Novartis Investigative Site", "city": "Petrozavodsk", "zip": "185019", "country": "Russian Federation", "geoPoint": {"lat": 61.78491, "lon": 34.34691}}, {"facility": "Novartis Investigative Site", "city": "Ryazan", "zip": "390026", "country": "Russian Federation", "geoPoint": {"lat": 54.6269, "lon": 39.6916}}, {"facility": "Novartis Investigative Site", "city": "Saint Petersburg", "zip": "194044", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Saint Petersburg", "zip": "198260", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Saratov", "zip": "410012", "country": "Russian Federation", "geoPoint": {"lat": 51.54056, "lon": 46.00861}}, {"facility": "Novartis Investigative Site", "city": "Smolensk", "zip": "214019", "country": "Russian Federation", "geoPoint": {"lat": 54.7818, "lon": 32.0401}}, {"facility": "Novartis Investigative Site", "city": "St-Petersburg", "zip": "194358", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "St.- Petersburg", "zip": "199034", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "Novartis Investigative Site", "city": "Bratislava", "state": "Slovak Republic", "zip": "85101", "country": "Slovakia", "geoPoint": {"lat": 48.14816, "lon": 17.10674}}, {"facility": "Novartis Investigative Site", "city": "Kosice", "state": "Slovak Republic", "zip": "04001", "country": "Slovakia", "geoPoint": {"lat": 48.71395, "lon": 21.25808}}, {"facility": "Novartis Investigative Site", "city": "Lucenec", "state": "Slovak Republic", "zip": "98401", "country": "Slovakia", "geoPoint": {"lat": 48.33249, "lon": 19.66708}}, {"facility": "Novartis Investigative Site", "city": "Namestovo", "state": "Slovak Republic", "zip": "02901", "country": "Slovakia", "geoPoint": {"lat": 49.4079, "lon": 19.48032}}, {"facility": "Novartis Investigative Site", "city": "Roznava", "state": "Slovak Republic", "zip": "04801", "country": "Slovakia", "geoPoint": {"lat": 48.66009, "lon": 20.53758}}, {"facility": "Novartis Investigative Site", "city": "Sala", "state": "Slovak Republic", "zip": "92701", "country": "Slovakia", "geoPoint": {"lat": 48.15127, "lon": 17.88062}}, {"facility": "Novartis Investigative Site", "city": "Trebisov", "state": "Slovak Republic", "zip": "075 01", "country": "Slovakia", "geoPoint": {"lat": 48.62858, "lon": 21.71954}}, {"facility": "Novartis Investigative Site", "city": "Zilina", "state": "Slovak Republic", "zip": "010 01", "country": "Slovakia", "geoPoint": {"lat": 49.22315, "lon": 18.73941}}, {"facility": "Novartis Investigative Site", "city": "Banska Bystrica", "zip": "974 01", "country": "Slovakia", "geoPoint": {"lat": 48.73946, "lon": 19.15349}}, {"facility": "Novartis Investigative Site", "city": "Kosice", "zip": "040 01", "country": "Slovakia", "geoPoint": {"lat": 48.71395, "lon": 21.25808}}, {"facility": "Novartis Investigative Site", "city": "Kosice", "zip": "040 22", "country": "Slovakia", "geoPoint": {"lat": 48.71395, "lon": 21.25808}}, {"facility": "Novartis Investigative Site", "city": "Levice", "zip": "934 01", "country": "Slovakia", "geoPoint": {"lat": 48.21563, "lon": 18.60705}}, {"facility": "Novartis Investigative Site", "city": "Nov\u00e9 Z\u00e1mky", "zip": "940 01", "country": "Slovakia", "geoPoint": {"lat": 47.98544, "lon": 18.16195}}, {"facility": "Novartis Investigative Site", "city": "Presov", "zip": "080 01", "country": "Slovakia", "geoPoint": {"lat": 48.99839, "lon": 21.23393}}, {"facility": "Novartis Investigative Site", "city": "Sabinov", "zip": "08301", "country": "Slovakia", "geoPoint": {"lat": 49.10309, "lon": 21.0988}}, {"facility": "Novartis Investigative Site", "city": "Sered", "zip": "92601", "country": "Slovakia", "geoPoint": {"lat": 48.29117, "lon": 17.73331}}, {"facility": "Novartis Investigative Site", "city": "Sturovo", "zip": "94301", "country": "Slovakia", "geoPoint": {"lat": 47.79495, "lon": 18.7175}}, {"facility": "Novartis Investigative Site", "city": "Zilina", "zip": "012 07", "country": "Slovakia", "geoPoint": {"lat": 49.22315, "lon": 18.73941}}, {"facility": "Novartis Investigative Site", "city": "Alberton", "zip": "1449", "country": "South Africa", "geoPoint": {"lat": -26.26786, "lon": 28.12225}}, {"facility": "Novartis Investigative Site", "city": "Cape Town", "zip": "7925", "country": "South Africa", "geoPoint": {"lat": -33.92584, "lon": 18.42322}}, {"facility": "Novartis Investigative Site", "city": "Durban", "zip": "4030", "country": "South Africa", "geoPoint": {"lat": -29.8579, "lon": 31.0292}}, {"facility": "Novartis Investigative Site", "city": "Durban", "zip": "4126", "country": "South Africa", "geoPoint": {"lat": -29.8579, "lon": 31.0292}}, {"facility": "Novartis Investigative Site", "city": "Gauteng", "country": "South Africa"}, {"facility": "Novartis Investigative Site", "city": "Johannesburg", "zip": "1820", "country": "South Africa", "geoPoint": {"lat": -26.20227, "lon": 28.04363}}, {"facility": "Novartis Investigative Site", "city": "Johannesburg", "zip": "2188", "country": "South Africa", "geoPoint": {"lat": -26.20227, "lon": 28.04363}}, {"facility": "Novartis Investigative Site", "city": "Pretoria", "zip": "0184", "country": "South Africa", "geoPoint": {"lat": -25.74486, "lon": 28.18783}}, {"facility": "Novartis Investigative Site", "city": "Pretoria", "zip": "1022", "country": "South Africa", "geoPoint": {"lat": -25.74486, "lon": 28.18783}}, {"facility": "Novartis Investigative Site", "city": "Sant Adria Del Besos", "state": "Barcelona", "zip": "08930", "country": "Spain"}, {"facility": "Novartis Investigative Site", "city": "Santa Coloma De Gramanet", "state": "Barcelona", "zip": "08921", "country": "Spain"}, {"facility": "Novartis Investigative Site", "city": "Barcelona", "state": "Catalu\u00f1a", "zip": "08025", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"facility": "Novartis Investigative Site", "city": "Barcelona", "zip": "08020", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"facility": "Novartis Investigative Site", "city": "Hsintien", "zip": "231", "country": "Taiwan"}, {"facility": "Novartis Investigative Site", "city": "Taichung", "zip": "40705", "country": "Taiwan", "geoPoint": {"lat": 24.1469, "lon": 120.6839}}, {"facility": "Novartis Investigative Site", "city": "Taipei", "zip": "114", "country": "Taiwan", "geoPoint": {"lat": 25.04776, "lon": 121.53185}}, {"facility": "Novartis Investigative Site", "city": "Taoyuan", "zip": "33305", "country": "Taiwan", "geoPoint": {"lat": 24.95233, "lon": 121.20193}}, {"facility": "Novartis Investigative Site", "city": "Adana", "zip": "01330", "country": "Turkey", "geoPoint": {"lat": 37.00167, "lon": 35.32889}}, {"facility": "Novartis Investigative Site", "city": "Antalya", "zip": "07070", "country": "Turkey", "geoPoint": {"lat": 36.90812, "lon": 30.69556}}, {"facility": "Novartis Investigative Site", "city": "Denizli", "zip": "20070", "country": "Turkey", "geoPoint": {"lat": 37.77417, "lon": 29.0875}}, {"facility": "Novartis Investigative Site", "city": "Diskapi / Ankara", "zip": "06770", "country": "Turkey"}, {"facility": "Novartis Investigative Site", "city": "Istanbul", "zip": "34093", "country": "Turkey", "geoPoint": {"lat": 41.01384, "lon": 28.94966}}, {"facility": "Novartis Investigative Site", "city": "Izmir", "zip": "35040", "country": "Turkey", "geoPoint": {"lat": 38.41273, "lon": 27.13838}}, {"facility": "Novartis Investigative Site", "city": "Izmir", "zip": "35340", "country": "Turkey", "geoPoint": {"lat": 38.41273, "lon": 27.13838}}, {"facility": "Novartis Investigative Site", "city": "Kahramanmaras", "zip": "46100", "country": "Turkey", "geoPoint": {"lat": 37.5847, "lon": 36.92641}}]}, "referencesModule": {"references": [{"pmid": "36170017", "type": "DERIVED", "citation": "Tsotra F, Kappel M, Peristeris P, Bader G, Levi E, Lister N, Malhotra A, Ostwald DA. The societal impact of early intensified treatment in patients with type 2 diabetes mellitus. J Comp Eff Res. 2022 Nov;11(16):1185-1199. doi: 10.2217/cer-2022-0110. Epub 2022 Sep 28."}, {"pmid": "34130731", "type": "DERIVED", "citation": "Vencio S, Manosalva JP, Mathieu C, Proot P, Lozno HY, Paldanius PM. Exploring early combination strategy in Latin American patients with newly diagnosed type 2 diabetes: a sub-analysis of the VERIFY study. Diabetol Metab Syndr. 2021 Jun 15;13(1):68. doi: 10.1186/s13098-021-00686-9."}, {"pmid": "32975711", "type": "DERIVED", "citation": "Matthews D, Del Prato S, Mohan V, Mathieu C, Vencio S, Chan JCN, Stumvoll M, Paldanius PM. Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes. Diabetes Ther. 2020 Nov;11(11):2465-2476. doi: 10.1007/s13300-020-00926-7. Epub 2020 Sep 25."}, {"pmid": "31542292", "type": "DERIVED", "citation": "Matthews DR, Paldanius PM, Proot P, Chiang Y, Stumvoll M, Del Prato S; VERIFY study group. Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial. Lancet. 2019 Oct 26;394(10208):1519-1529. doi: 10.1016/S0140-6736(19)32131-2. Epub 2019 Sep 18."}, {"pmid": "30576013", "type": "DERIVED", "citation": "Matthews DR, Paldanius PM, Proot P, Foley JE, Stumvoll M, Del Prato S. Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin-metformin combination in newly diagnosed Type 2 diabetes. Diabet Med. 2019 Apr;36(4):505-513. doi: 10.1111/dme.13886. Epub 2019 Feb 12."}]}, "ipdSharingStatementModule": {"ipdSharing": "YES", "description": "Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.\n\nThis trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com"}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "It was planned to screen approximately 4000 patients in order to randomize 2000 patients. Actually, 2001 patients were randomized, 998 patients into the Vilda 50mg bid + metformin group and 1003 into the placebo + metformin group.", "groups": [{"id": "FG000", "title": "Vilda 50mg Bid + Metformin", "description": "vildagliptin (Vilda 50mg bid) + Metformin"}, {"id": "FG001", "title": "Placebo + Metformin", "description": "Placebo of vildagliptin (Vilda 50mg bid) + Metformin"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "comment": "All randomized patients (RAN)", "achievements": [{"groupId": "FG000", "numSubjects": "998"}, {"groupId": "FG001", "numSubjects": "1003"}]}, {"type": "Safety Set", "comment": "At least one dose of study medication", "achievements": [{"groupId": "FG000", "numSubjects": "998"}, {"groupId": "FG001", "numSubjects": "1001"}]}, {"type": "Full Analysis Set (FAS)", "comment": "At least one randomized study medication and a post-randomization efficacy parameter assessment.", "achievements": [{"groupId": "FG000", "numSubjects": "983"}, {"groupId": "FG001", "numSubjects": "989"}]}, {"type": "Completed Treatment Period 1", "achievements": [{"groupId": "FG000", "numSubjects": "458"}, {"groupId": "FG001", "numSubjects": "273"}]}, {"type": "Completed Treatment Period 2", "achievements": [{"groupId": "FG000", "numSubjects": "244"}, {"groupId": "FG001", "numSubjects": "399"}]}, {"type": "Completed Treatment Period 3", "achievements": [{"groupId": "FG000", "numSubjects": "109"}, {"groupId": "FG001", "numSubjects": "115"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "811"}, {"groupId": "FG001", "numSubjects": "787"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "187"}, {"groupId": "FG001", "numSubjects": "216"}]}], "dropWithdraws": [{"type": "Administrative problems", "reasons": [{"groupId": "FG000", "numSubjects": "96"}, {"groupId": "FG001", "numSubjects": "94"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "28"}, {"groupId": "FG001", "numSubjects": "44"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "17"}, {"groupId": "FG001", "numSubjects": "24"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "13"}, {"groupId": "FG001", "numSubjects": "9"}]}, {"type": "Protocol deviation", "reasons": [{"groupId": "FG000", "numSubjects": "9"}, {"groupId": "FG001", "numSubjects": "19"}]}, {"type": "New therapy for study indication", "reasons": [{"groupId": "FG000", "numSubjects": "8"}, {"groupId": "FG001", "numSubjects": "6"}]}, {"type": "Unsatisfactory therapeutic effect", "reasons": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "8"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "4"}]}, {"type": "Abnormal laboratory value(s)", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "7"}]}, {"type": "Abnormal test procedure result(s)", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "No longer requires study drug", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Vilda 50mg Bid + Metformin", "description": "vildagliptin (Vilda 50mg bid) + Metformin"}, {"id": "BG001", "title": "Placebo + Metformin", "description": "Placebo of vildagliptin (Vilda 50mg bid) + Metformin"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "998"}, {"groupId": "BG001", "value": "1003"}, {"groupId": "BG002", "value": "2001"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "998"}, {"groupId": "BG001", "value": "1003"}, {"groupId": "BG002", "value": "2001"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "54.1", "spread": "9.54"}, {"groupId": "BG001", "value": "54.6", "spread": "9.24"}, {"groupId": "BG002", "value": "54.3", "spread": "9.39"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "998"}, {"groupId": "BG001", "value": "1003"}, {"groupId": "BG002", "value": "2001"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "545"}, {"groupId": "BG001", "value": "515"}, {"groupId": "BG002", "value": "1060"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "453"}, {"groupId": "BG001", "value": "488"}, {"groupId": "BG002", "value": "941"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "Participants", "classes": [{"title": "Caucasian", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "998"}, {"groupId": "BG001", "value": "1003"}, {"groupId": "BG002", "value": "2001"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "605"}, {"groupId": "BG001", "value": "612"}, {"groupId": "BG002", "value": "1217"}]}]}, {"title": "Black", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "998"}, {"groupId": "BG001", "value": "1003"}, {"groupId": "BG002", "value": "2001"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "26"}, {"groupId": "BG001", "value": "23"}, {"groupId": "BG002", "value": "49"}]}]}, {"title": "Asian", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "998"}, {"groupId": "BG001", "value": "1003"}, {"groupId": "BG002", "value": "2001"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "186"}, {"groupId": "BG001", "value": "187"}, {"groupId": "BG002", "value": "373"}]}]}, {"title": "Native American", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "998"}, {"groupId": "BG001", "value": "1003"}, {"groupId": "BG002", "value": "2001"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "103"}, {"groupId": "BG001", "value": "107"}, {"groupId": "BG002", "value": "210"}]}]}, {"title": "Other", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "998"}, {"groupId": "BG001", "value": "1003"}, {"groupId": "BG002", "value": "2001"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "78"}, {"groupId": "BG001", "value": "74"}, {"groupId": "BG002", "value": "152"}]}]}]}, {"title": "glycosylated hemoglobin (HbA1c)", "description": "Baseline HbA1c is the sample obtained on day 1, or the sample obtained at an earlier visit (scheduled or unscheduled) which was closest to Day 1, if the Day 1 measurement is missing.", "populationDescription": "Only patients with at least one measurement on or prior to Day 1 are included.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Percent", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "996"}, {"groupId": "BG001", "value": "1003"}, {"groupId": "BG002", "value": "1999"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "6.7", "spread": "0.45"}, {"groupId": "BG001", "value": "6.7", "spread": "0.47"}, {"groupId": "BG002", "value": "6.7", "spread": "0.46"}]}]}]}, {"title": "fasting plasma glucose (FPG)", "description": "Baseline FPG is the sample obtained on day 1, or the sample obtained at an earlier visit (scheduled or unscheduled) which was closest to Day 1, if the Day 1 measurement is missing.", "populationDescription": "Only patients with at least one measurement on or prior to Day 1 are included.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "mmol/l", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "996"}, {"groupId": "BG001", "value": "1003"}, {"groupId": "BG002", "value": "1999"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "7.1", "spread": "1.40"}, {"groupId": "BG001", "value": "7.2", "spread": "1.47"}, {"groupId": "BG002", "value": "7.1", "spread": "1.44"}]}]}]}, {"title": "Duration of type 2 diabetes", "description": "Duration of type 2 diabetes is collected on the day of the screening measurement (Week -5, Visit 1)", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "months", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "998"}, {"groupId": "BG001", "value": "1003"}, {"groupId": "BG002", "value": "2001"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "6.2", "spread": "7.00"}, {"groupId": "BG001", "value": "6.6", "spread": "8.05"}, {"groupId": "BG002", "value": "6.4", "spread": "7.55"}]}]}]}, {"title": "Glomerular Filtration Rate (Modification of Diet in Renal Disease)", "description": "GFR (MDRD) = GFR estimated using the MDRD formula. Baseline GFR is calculated using the serum creatinine and body weight value at the Day 1 measurement, or the value obtained at an earlier visit (scheduled or unscheduled) which was closest to Day 1, if the Day 1 measurement is missing. Age is the value at screening.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "998"}, {"groupId": "BG001", "value": "1003"}, {"groupId": "BG002", "value": "2001"}]}], "categories": [{"title": "Normal (>80)", "measurements": [{"groupId": "BG000", "value": "660"}, {"groupId": "BG001", "value": "661"}, {"groupId": "BG002", "value": "1321"}]}, {"title": "Mild (>=50 - <=80)", "measurements": [{"groupId": "BG000", "value": "333"}, {"groupId": "BG001", "value": "337"}, {"groupId": "BG002", "value": "670"}]}, {"title": "Moderate (>=30 - <50)", "measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "7"}]}, {"title": "Severe (<30)", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}]}, {"title": "Missing", "measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "2"}]}]}]}, {"title": "Is subject a current smoker?", "description": "Smoking status is collected on the day of the screening measurement (Week -5, Visit 1)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "998"}, {"groupId": "BG001", "value": "1003"}, {"groupId": "BG002", "value": "2001"}]}], "categories": [{"title": "Is subject a current smoker?=Yes", "measurements": [{"groupId": "BG000", "value": "154"}, {"groupId": "BG001", "value": "136"}, {"groupId": "BG002", "value": "290"}]}, {"title": "Is subject a current smoker?=No", "measurements": [{"groupId": "BG000", "value": "844"}, {"groupId": "BG001", "value": "867"}, {"groupId": "BG002", "value": "1711"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Time to Initial Treatment Failure", "description": "Treatment failure was defined as two consecutive scheduled visits with HbA1c \\>= 7.0% (starting from 13 weeks after randomization) and the time to treatment failure was the number of days from randomization to the second of the consecutive scheduled visits.\n\nParticipants who discontinued the study for any reason during Period 1 were censored at the date of discontinuation. Participants who remained under the threshold (or whose measurement above the threshold was not confirmed at next scheduled visit) were censored at the date of last study visit.", "populationDescription": "Full Analysis Set (FAS)", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Rate (%)", "timeFrame": "Visit 4 (Week 13) up to End of Study (Study Drug Discontinuation or Premature Subject Discontinuation)", "groups": [{"id": "OG000", "title": "Vilda 50mg Bid + Metformin", "description": "vildagliptin (Vilda 50mg bid) + Metformin"}, {"id": "OG001", "title": "Placebo + Metformin", "description": "Placebo of vildagliptin (Vilda 50mg bid) + Metformin"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "983"}, {"groupId": "OG001", "value": "989"}]}], "classes": [{"title": "Weeks 13-52", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "75"}, {"groupId": "OG001", "value": "192"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7.81", "lowerLimit": "6.28", "upperLimit": "9.70"}, {"groupId": "OG001", "value": "19.97", "lowerLimit": "17.58", "upperLimit": "22.65"}]}]}, {"title": "Year 2", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "168"}, {"groupId": "OG001", "value": "326"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "17.79", "lowerLimit": "15.49", "upperLimit": "20.38"}, {"groupId": "OG001", "value": "34.67", "lowerLimit": "31.72", "upperLimit": "37.82"}]}]}, {"title": "Year 3", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "290"}, {"groupId": "OG001", "value": "446"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "31.24", "lowerLimit": "28.35", "upperLimit": "34.33"}, {"groupId": "OG001", "value": "48.31", "lowerLimit": "45.12", "upperLimit": "51.61"}]}]}, {"title": "Year 4", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "365"}, {"groupId": "OG001", "value": "540"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "39.84", "lowerLimit": "36.74", "upperLimit": "43.11"}, {"groupId": "OG001", "value": "59.29", "lowerLimit": "56.08", "upperLimit": "62.53"}]}]}, {"title": "Year 5", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "421"}, {"groupId": "OG001", "value": "600"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "46.41", "lowerLimit": "43.20", "upperLimit": "49.74"}, {"groupId": "OG001", "value": "66.57", "lowerLimit": "63.43", "upperLimit": "69.69"}]}]}, {"title": "> Year 5", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "429"}, {"groupId": "OG001", "value": "614"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "52.67", "lowerLimit": "44.29", "upperLimit": "61.58"}, {"groupId": "OG001", "value": "74.39", "lowerLimit": "68.39", "upperLimit": "80.04"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "0.51", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.45", "ciUpperLimit": "0.58"}]}, {"type": "SECONDARY", "title": "Rate of Loss in Glycemic Control During Period 1", "description": "The rate of loss in glycemic control was estimated using the slope of HbA1c over time (years).\n\nHbA1c data collected from Week 26 up to and including the end of Period 1 visit was included in the analysis. Baseline HbA1c was the sample obtained on day 1, or the sample obtained at an earlier visit (scheduled or unscheduled) which was closest to Day 1, if the Day 1 measurement was missing. End of Period 1 was defined as the final post-baseline assessment obtained at any visit within Period 1 (scheduled or unscheduled), up to the last scheduled visit.", "populationDescription": "Full Analysis Set (FAS)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Rate (%)", "timeFrame": "Visit 5 (Week 26) to End of Period 1", "groups": [{"id": "OG000", "title": "Vilda 50mg Bid + Metformin", "description": "vildagliptin (Vilda 50mg bid) + Metformin"}, {"id": "OG001", "title": "Placebo + Metformin", "description": "Placebo of vildagliptin (Vilda 50mg bid) + Metformin"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "983"}, {"groupId": "OG001", "value": "989"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.24", "spread": "0.01"}, {"groupId": "OG001", "value": "0.27", "spread": "0.01"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "OTHER", "pValue": "0.042", "statisticalMethod": "Mixed Models Analysis", "paramType": "Slope", "paramValue": "-0.02", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.05", "ciUpperLimit": "0.00", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.01"}]}, {"type": "SECONDARY", "title": "Rate of Loss in Glycemic Control in HbA1c Over Time During Period 2", "description": "The rate of loss in glycemic control was estimated using the slope of HbA1c over time (years).\n\nHbA1c data collected from 26 weeks after the start of Period 2 to the end of Period 2 were included in the analysis, for participants who started insulin therapy in Period 3 or discontinued during Period 2 due to being unable or unwilling to initiate insulin therapy in period 3. Participants who completed the study in Period 1 or Period 2 were not be included in the analysis.", "populationDescription": "Full Analysis Set (FAS)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Rate (%)", "timeFrame": "From 26 weeks after start of Period 2 to end of Period 2", "groups": [{"id": "OG000", "title": "Vilda 50mg Bid + Metformin", "description": "vildagliptin (Vilda 50mg bid) + Metformin"}, {"id": "OG001", "title": "Placebo + Metformin", "description": "Placebo of vildagliptin (Vilda 50mg bid) + Metformin"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "410"}, {"groupId": "OG001", "value": "588"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1.11", "spread": "0.15"}, {"groupId": "OG001", "value": "1.02", "spread": "0.12"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "OTHER", "pValue": "0.635", "statisticalMethod": "Mixed Models Analysis", "paramType": "Slope", "paramValue": "0.09", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.29", "ciUpperLimit": "0.47", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.19"}]}, {"type": "SECONDARY", "title": "Rate of Loss in Glycemic Control in Fasting Plasma Glucose (FPG) During Period 1", "description": "Rate of loss in glycemic control was estimated using the slope of FPG over time (years).\n\nFPG (fasting plasma glucose) data from Week 26 to the end of Period 1 was included in the analysis. Baseline FPG was the sample obtained on day 1, or the sample obtained at an earlier visit (scheduled or unscheduled) which was closest to Day 1, if the Day 1 measurement is missing. Participants who completed the study in Period 1 or Period 2 were not be included in the analysis.", "populationDescription": "Full Analysis Set (FAS)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Rate (%)", "timeFrame": "Visit 5 (Week 26) to End of Period 1", "groups": [{"id": "OG000", "title": "Vilda 50mg Bid + Metformin", "description": "vildagliptin (Vilda 50mg bid) + Metformin"}, {"id": "OG001", "title": "Placebo + Metformin", "description": "Placebo of vildagliptin (Vilda 50mg bid) + Metformin"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "983"}, {"groupId": "OG001", "value": "989"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.25", "spread": "0.01"}, {"groupId": "OG001", "value": "0.26", "spread": "0.01"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "OTHER", "pValue": "0.530", "statisticalMethod": "Mixed Models Analysis", "paramType": "Slope", "paramValue": "-0.01", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.05", "ciUpperLimit": "0.02", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.02"}]}, {"type": "SECONDARY", "title": "Rate of Loss in Glycemic Control in Fasting Plasma Glucose (FPG) Over Time During Period 2", "description": "Rate of loss in glycemic control was estimated using the slope of FPG over time (years).\n\nFPG (fasting plasma glucose) data from 26 weeks after the start of Period 2 to then end of Period 2 was included in the analysis. Only participants who started insulin therapy in Period 3 or discontinued during Period 2 due to being unable or unwilling to initiate insulin therapy in period 3 were included. Participants who completed the study in Period 1 or Period 2 were not be included in the analysis.", "populationDescription": "Full Analysis Set (FAS)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Rate (%)", "timeFrame": "From 26 weeks after start of Period 2 to end of Period 2", "groups": [{"id": "OG000", "title": "Vilda 50mg Bid + Metformin", "description": "vildagliptin (Vilda 50mg bid) + Metformin"}, {"id": "OG001", "title": "Placebo + Metformin", "description": "Placebo of vildagliptin (Vilda 50mg bid) + Metformin"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "410"}, {"groupId": "OG001", "value": "588"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1.27", "spread": "0.25"}, {"groupId": "OG001", "value": "0.99", "spread": "0.19"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "OTHER", "pValue": "0.381", "statisticalMethod": "Mixed Models Analysis", "paramType": "Slope", "paramValue": "0.28", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.35", "ciUpperLimit": "0.90", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.32"}]}, {"type": "SECONDARY", "title": "Rate of Loss of Beta Cell Function From Baseline to End of Study", "description": "The rate of change of beta cell function was assessed using the slope of AUC of ISR/G over time (years) where AUC of ISR/G is defined as (Area under curve of Insulin secretion rate (derived using c-peptide))/(Area under curve of Glucose), using meal-test data from 0 to 120 minutes. Baseline AUC of ISR/G was derived based on samples obtained on day 1, or samples obtained at an earlier visit (scheduled or unscheduled) which was closest to Day 1, if the Day 1 measurements were missing. Three analyses were included, using data from Week 13 to the end of Period 1, end of Period 2 and end of study, respectively.", "populationDescription": "Full Analysis Set (FAS) meal-test subset", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Rate (%)", "timeFrame": "Visit 4 (Week 13), End of Period 1, End of Period 2, End of Study (Study Drug Discontinuation or Premature Subject Discontinuation)", "groups": [{"id": "OG000", "title": "Vilda 50mg Bid + Metformin", "description": "vildagliptin (Vilda 50mg bid) + Metformin"}, {"id": "OG001", "title": "Placebo + Metformin", "description": "Placebo of vildagliptin (Vilda 50mg bid) + Metformin"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "228"}, {"groupId": "OG001", "value": "227"}]}], "classes": [{"title": "From Week 13 to end of Period 1", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "201"}, {"groupId": "OG001", "value": "202"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.60", "spread": "0.15"}, {"groupId": "OG001", "value": "-0.53", "spread": "0.18"}]}]}, {"title": "From Week 13 to end of Period 2", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "202"}, {"groupId": "OG001", "value": "204"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.93", "spread": "0.14"}, {"groupId": "OG001", "value": "-0.43", "spread": "0.15"}]}]}, {"title": "From Week 13 to end of study", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "202"}, {"groupId": "OG001", "value": "204"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.04", "spread": "0.15"}, {"groupId": "OG001", "value": "-0.46", "spread": "0.15"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "From Week 13 to end of Period 1", "nonInferiorityType": "OTHER", "pValue": "0.744", "statisticalMethod": "Mixed Models Analysis", "paramType": "Slope", "paramValue": "-0.08", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.53", "ciUpperLimit": "0.38", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.23"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "From Week 13 to end of Period 2", "nonInferiorityType": "OTHER", "pValue": "0.017", "statisticalMethod": "Mixed Models Analysis", "paramType": "Slope", "paramValue": "-0.50", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.91", "ciUpperLimit": "-0.09", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.21"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "From Week 13 to end of study", "nonInferiorityType": "OTHER", "pValue": "0.006", "statisticalMethod": "Mixed Models Analysis", "paramType": "Slope", "paramValue": "-0.58", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.99", "ciUpperLimit": "-0.17", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.21"}]}, {"type": "SECONDARY", "title": "Rate of Change in Insulin Sensitivity From Baseline to End of Study", "description": "The rate of change of insulin sensitivity is assessed using the slope of OGIS over time (years) where Oral glucose insulin sensitivity (OGIS) was calculated as a function of glucose and insulin, using meal-test data from 0 to 120 minutes. Baseline OGIS is derived based on samples obtained on day 1, or samples obtained at an earlier visit (scheduled or unscheduled) which was closest to Day 1, if the Day 1 measurements are missing. Three analyses were included, using data from Week 13 to the end of Period 1, end of Period 2 and end of study, respectively.", "populationDescription": "Full Analysis Set (FAS) meal-test subset", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Rate (%)", "timeFrame": "Visit 4 (Week 13), End of Period 1, End of Period 2, End of Study (Study Drug Discontinuation or Premature Subject Discontinuation)", "groups": [{"id": "OG000", "title": "Vilda 50mg Bid + Metformin", "description": "vildagliptin (Vilda 50mg bid) + Metformin"}, {"id": "OG001", "title": "Placebo + Metformin", "description": "Placebo of vildagliptin (Vilda 50mg bid) + Metformin"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "228"}, {"groupId": "OG001", "value": "227"}]}], "classes": [{"title": "From Week 13 to end of Period 1", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "189"}, {"groupId": "OG001", "value": "193"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.61", "spread": "1.38"}, {"groupId": "OG001", "value": "0.41", "spread": "1.66"}]}]}, {"title": "From Week 13 to end of Period 2", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "190"}, {"groupId": "OG001", "value": "194"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-6.07", "spread": "1.20"}, {"groupId": "OG001", "value": "-0.99", "spread": "1.24"}]}]}, {"title": "From Week 13 to end of study", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "190"}, {"groupId": "OG001", "value": "194"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "-6.39", "spread": "1.15"}, {"groupId": "OG001", "value": "-1.01", "spread": "1.17"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "From Week 13 to end of Period 1", "nonInferiorityType": "OTHER", "pValue": "0.020", "statisticalMethod": "Mixed Models Analysis", "paramType": "Slope", "paramValue": "-5.03", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-9.26", "ciUpperLimit": "-0.79", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "2.16"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "From Week 13 to end of Period 2", "nonInferiorityType": "OTHER", "pValue": "0.003", "statisticalMethod": "Mixed Models Analysis", "paramType": "Slope", "paramValue": "-5.08", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-8.46", "ciUpperLimit": "-1.69", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "1.73"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "From Week 13 to end of study", "nonInferiorityType": "OTHER", "pValue": "0.001", "statisticalMethod": "Mixed Models Analysis", "paramType": "Slope", "paramValue": "-5.38", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-8.61", "ciUpperLimit": "-2.16", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "1.64"}]}, {"type": "SECONDARY", "title": "Percentage of Participants With Adverse Events, Serious Adverse Events and Death", "description": "Analysis of absolute and relative frequencies for treatment emergent Adverse Event (AE), Serious Adverse Event (SAE) and Deaths by primary System Organ Class (SOC) in each treatment arm to demonstrate that LAF237 is safe for the treatment of na\u00efve patients with type 2 diabetes mellitus through the monitoring of relevant clinical and laboratory safety parameters.", "populationDescription": "Safety Set (SAF). Percentages are based on the number of patients starting each period.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Percentage of Participants", "timeFrame": "From first dose of study treatment until End of Study (Study Drug Discontinuation or Premature Subject Discontinuation)", "groups": [{"id": "OG000", "title": "Vilda 50mg Bid + Metformin", "description": "vildagliptin (Vilda 50mg bid) + Metformin"}, {"id": "OG001", "title": "Placebo + Metformin", "description": "Placebo of vildagliptin (Vilda 50mg bid) + Metformin"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "998"}, {"groupId": "OG001", "value": "1001"}]}], "classes": [{"title": "On-treatment Adverse Event (AEs)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "833"}, {"groupId": "OG001", "value": "833"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "83.5"}, {"groupId": "OG001", "value": "83.2"}]}]}, {"title": "On-treatment Serious Adverse Event (SAEs)", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "166"}, {"groupId": "OG001", "value": "183"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "16.6"}, {"groupId": "OG001", "value": "18.3"}]}]}, {"title": "On-treatment Deaths", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "9"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.3"}, {"groupId": "OG001", "value": "0.9"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "Adverse events were collected from first dose of study treatment until end of study treatment plus 30 days post treatment, up to a maximum duration of 75.6 months.", "description": "Any sign or symptom that occurs during the study treatment plus the 30 days post treatment. Maximum exposure to study treatments = 75.6 months (Vilda 50mg bid + metformin arm) and 66.2 months (Placebo + metformin arm).", "eventGroups": [{"id": "EG000", "title": "Vilda 50mg Bid + Metformin", "description": "vildagliptin (Vilda 50mg bid) + Metformin", "deathsNumAffected": 13, "deathsNumAtRisk": 998, "seriousNumAffected": 166, "seriousNumAtRisk": 998, "otherNumAffected": 582, "otherNumAtRisk": 998}, {"id": "EG001", "title": "Placebo + Metformin", "description": "Placebo of vildagliptin (Vilda 50mg bid) + Metformin", "deathsNumAffected": 9, "deathsNumAtRisk": 1001, "seriousNumAffected": 183, "seriousNumAtRisk": 1001, "otherNumAffected": 566, "otherNumAtRisk": 1001}, {"id": "EG002", "title": "Total", "description": "Total", "deathsNumAffected": 22, "deathsNumAtRisk": 1999, "seriousNumAffected": 349, "seriousNumAtRisk": 1999, "otherNumAffected": 1148, "otherNumAtRisk": 1999}], "seriousEvents": [{"term": "Anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Cytopenia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hypochromic anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Iron deficiency anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Lymphadenopathy mediastinal", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Acute coronary syndrome", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Acute myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 1999}]}, {"term": "Angina pectoris", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 1999}]}, {"term": "Angina unstable", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Aortic valve incompetence", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Arrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 11, "numAtRisk": 1999}]}, {"term": "Atrial flutter", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Atrioventricular block complete", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Atrioventricular block second degree", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Bundle branch block left", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Cardiac arrest", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 1999}]}, {"term": "Cardiac failure acute", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Cardiac failure chronic", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Cardiac failure congestive", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Cardiogenic shock", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Conduction disorder", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Coronary artery disease", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 1999}]}, {"term": "Coronary artery insufficiency", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Coronary artery stenosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 1999}]}, {"term": "Mitral valve disease", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 10, "numAtRisk": 1999}]}, {"term": "Myocardial ischaemia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 1999}]}, {"term": "Sinus node dysfunction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Sinus tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Supraventricular extrasystoles", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Supraventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Ventricular fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Ventricular hypokinesia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Ventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Congenital intestinal malformation", "organSystem": "Congenital, familial and genetic disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Heart disease congenital", "organSystem": "Congenital, familial and genetic disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Acute vestibular syndrome", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Deafness neurosensory", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Tinnitus", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Vertigo", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Vertigo positional", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Goitre", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Hypoparathyroidism", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Diplopia", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Vitreous haemorrhage", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Abdominal hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Abdominal pain", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Abdominal pain lower", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Abdominal pain upper", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Anal fissure", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Anal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Ascites", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Colitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Duodenal ulcer haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Food poisoning", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Gastric disorder", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Gastric mucosal lesion", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Gastric ulcer", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Gastrointestinal erosion", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Gastrointestinal fistula", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Gastrointestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Gastrooesophageal reflux disease", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Ileus", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Inguinal hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 1999}]}, {"term": "Lumbar hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pancreatitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pancreatitis acute", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Rectal prolapse", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Retroperitoneal fibrosis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Umbilical hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 1999}]}, {"term": "Upper gastrointestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Varices oesophageal", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Vomiting", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Death", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Granuloma", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Inflammation", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Non-cardiac chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Oedema peripheral", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Peripheral swelling", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Stent-graft endoleak", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Sudden death", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Biliary colic", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Cholangitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Cholecystitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 4, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 1999}]}, {"term": "Cholecystitis acute", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 1999}]}, {"term": "Cholelithiasis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 1999}]}, {"term": "Cholestasis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hepatic cirrhosis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hepatic cyst", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hepatic failure", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hepatic steatosis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hepatitis toxic", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hepatorenal syndrome", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hydrocholecystis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Jaundice cholestatic", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Liver disorder", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Anaphylactic reaction", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Abscess limb", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Acute sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Anal abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Appendicitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 1999}]}, {"term": "Bartholin's abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Bone tuberculosis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Cervicitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Dengue fever", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Diarrhoea infectious", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Diverticulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Epididymitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Gastroenteritis viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hepatic echinococciasis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hepatitis viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Herpes zoster", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Lung infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Mastoiditis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Meningitis pneumococcal", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Otitis media chronic", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pancreas infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 14, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 19, "numAtRisk": 1999}]}, {"term": "Pyelonephritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pyelonephritis acute", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pyelonephritis chronic", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Rectal abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Subcutaneous abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Tooth abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 1999}]}, {"term": "Urinary tract infection bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Viral infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Viral myelitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Ankle fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Burns first degree", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Clavicle fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Concussion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Craniocerebral injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Face injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Forearm fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Gun shot wound", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Heat stroke", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hip fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Humerus fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Joint dislocation", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Joint injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Ligament rupture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Limb injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Lower limb fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Lumbar vertebral fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Meniscus injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 1999}]}, {"term": "Multiple injuries", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Muscle rupture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Post procedural fistula", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Radius fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Rib fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Road traffic accident", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Skin abrasion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Skull fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Tendon rupture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Tooth fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Traumatic arthrosis", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Ulna fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Upper limb fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Alanine aminotransferase increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Aspartate aminotransferase increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Blood lactate dehydrogenase increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Gamma-glutamyltransferase increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "HIV test positive", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Transaminases increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Diabetes mellitus", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Diabetes mellitus inadequate control", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Hyperglycaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hyperkalaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Type 2 diabetes mellitus", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Exostosis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Gouty tophus", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Intervertebral disc protrusion", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 1999}]}, {"term": "Joint contracture", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Joint range of motion decreased", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Lumbar spinal stenosis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Musculoskeletal chest pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Myalgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Osteoarthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 1999}]}, {"term": "Osteochondrosis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Pain in extremity", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Periarthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pseudarthrosis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Rotator cuff syndrome", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Scleroderma", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Spinal osteoarthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 1999}]}, {"term": "Spinal pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Tendonitis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Adenocarcinoma gastric", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Adenoma benign", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "B-cell lymphoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Basal cell carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Bladder cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Brain neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Breast cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 1999}]}, {"term": "Breast cancer female", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Choroid melanoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Chronic lymphocytic leukaemia", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Chronic myeloid leukaemia", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Colon cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Cystadenocarcinoma ovary", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Endometrial cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Gallbladder neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Gastric cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Haemangioma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hepatic neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Intestinal adenocarcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Invasive ductal breast carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Kaposi's sarcoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Lung neoplasm malignant", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Malignant melanoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Malignant splenic neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Metastases to bone", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Metastases to central nervous system", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Metastases to liver", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Metastases to lung", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Metastases to lymph nodes", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Neuroendocrine tumour", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Oligoastrocytoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Ovarian adenoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Ovarian cancer metastatic", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Ovarian epithelial cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Ovarian neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pancreatic carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 1999}]}, {"term": "Parathyroid tumour benign", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Prostate cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 1999}]}, {"term": "Prostatic adenoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Rectal cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Rectosigmoid cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Refractory cytopenia with multilineage dysplasia", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Renal cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Renal neoplasm", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Skin cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Skin papilloma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Small cell carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Superficial spreading melanoma stage unspecified", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Thyroid cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Tongue neoplasm malignant stage unspecified", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Tumour haemorrhage", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Undifferentiated sarcoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Uterine leiomyoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Brain oedema", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Carotid artery stenosis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Carpal tunnel syndrome", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Cerebral haemorrhage", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Cerebral infarction", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Cerebral ischaemia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 1999}]}, {"term": "Cerebrovascular accident", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 1999}]}, {"term": "Cerebrovascular disorder", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Coma", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Demyelination", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Haemorrhage intracranial", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Haemorrhagic stroke", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hemiparesis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Intracranial pressure increased", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Ischaemic stroke", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 5, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 1999}]}, {"term": "Loss of consciousness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Lumbar radiculopathy", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Monoparesis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Paraesthesia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Radiculopathy", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Sciatica", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 4, "numAtRisk": 1999}]}, {"term": "Seizure", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Thrombotic cerebral infarction", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Transient ischaemic attack", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Vertebrobasilar insufficiency", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Abortion missed", "organSystem": "Pregnancy, puerperium and perinatal conditions", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Abortion spontaneous", "organSystem": "Pregnancy, puerperium and perinatal conditions", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Abortion threatened", "organSystem": "Pregnancy, puerperium and perinatal conditions", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pregnancy with contraceptive device", "organSystem": "Pregnancy, puerperium and perinatal conditions", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Depression", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Eating disorder", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Bladder tamponade", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Calculus bladder", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Chronic kidney disease", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Diabetic nephropathy", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Dysuria", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Haematuria", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hydronephrosis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Nephrolithiasis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 1999}]}, {"term": "Renal colic", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Renal failure", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Renal impairment", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Stag horn calculus", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Ureterolithiasis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Urethral stenosis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Urinary incontinence", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Urinary retention", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Urinary tract obstruction", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Benign prostatic hyperplasia", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Cervical cyst", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Dysfunctional uterine bleeding", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Endometrial hyperplasia", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Endometrial thickening", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Endometriosis", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Genital ulceration", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Metrorrhagia", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Ovarian cyst", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 1999}]}, {"term": "Ovarian fibrosis", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Prostatomegaly", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Uterine polyp", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}, {"term": "Acute respiratory failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Chronic obstructive pulmonary disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 5, "numAtRisk": 1999}]}, {"term": "Chronic respiratory failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Laryngeal cyst", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pneumonitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pulmonary embolism", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pulmonary mass", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Respiratory failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Angioedema", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Diabetic foot", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Eczema", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Skin lesion", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Skin ulcer haemorrhage", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Urticaria", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Aortic aneurysm", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Aortic dissection", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Aortic stenosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Deep vein thrombosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Haematoma", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 6, "numAtRisk": 1999}]}, {"term": "Hypertensive crisis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pelvic venous thrombosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Peripheral arterial occlusive disease", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Peripheral artery stenosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Peripheral venous disease", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Varicose vein", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 1999}]}], "otherEvents": [{"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 104, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 104, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 208, "numAtRisk": 1999}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 58, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 59, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 117, "numAtRisk": 1999}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 93, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 64, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 157, "numAtRisk": 1999}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 104, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 108, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 212, "numAtRisk": 1999}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 83, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 69, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 152, "numAtRisk": 1999}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 72, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 69, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 141, "numAtRisk": 1999}]}, {"term": "Dyslipidaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 58, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 71, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 129, "numAtRisk": 1999}]}, {"term": "Arthralgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 100, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 94, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 194, "numAtRisk": 1999}]}, {"term": "Back pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 105, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 86, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 191, "numAtRisk": 1999}]}, {"term": "Osteoarthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 54, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 40, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 94, "numAtRisk": 1999}]}, {"term": "Pain in extremity", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 67, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 74, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 141, "numAtRisk": 1999}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 67, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 41, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 108, "numAtRisk": 1999}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 82, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 72, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 154, "numAtRisk": 1999}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (21.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 103, "numAtRisk": 998}, {"groupId": "EG001", "numAffected": 124, "numAtRisk": 1001}, {"groupId": "EG002", "numAffected": 227, "numAtRisk": 1999}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (ie, data from all sites) in the clinical trial."}, "pointOfContact": {"title": "Study Director", "organization": "Novartis Pharmaceuticals", "email": "Novartis.email@novartis.com", "phone": "862-778-8300"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2019-12-17", "uploadDate": "2020-03-30T09:38", "filename": "SAP_000.pdf", "size": 1000187}, {"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2019-10-22", "uploadDate": "2020-03-30T09:38", "filename": "Prot_001.pdf", "size": 663005}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "removedCountries": ["Canada", "Costa Rica", "Czech Republic", "Ecuador"]}, "conditionBrowseModule": {"meshes": [{"id": "D000003920", "term": "Diabetes Mellitus"}, {"id": "D000003924", "term": "Diabetes Mellitus, Type 2"}], "ancestors": [{"id": "D000044882", "term": "Glucose Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}, {"id": "D000004700", "term": "Endocrine System Diseases"}], "browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "asFound": "Diabetes Mellitus", "relevance": "HIGH"}, {"id": "M7119", "name": "Diabetes Mellitus, Type 2", "asFound": "Type 2 Diabetes Mellitus", "relevance": "HIGH"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M25403", "name": "Glucose Metabolism Disorders", "relevance": "LOW"}, {"id": "M7862", "name": "Endocrine System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000008687", "term": "Metformin"}, {"id": "D000077597", "term": "Vildagliptin"}], "ancestors": [{"id": "D000007004", "term": "Hypoglycemic Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000054873", "term": "Dipeptidyl-Peptidase IV Inhibitors"}, {"id": "D000011480", "term": "Protease Inhibitors"}, {"id": "D000004791", "term": "Enzyme Inhibitors"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M11667", "name": "Metformin", "asFound": "Assessment", "relevance": "HIGH"}, {"id": "M1857", "name": "Vildagliptin", "asFound": "100%", "relevance": "HIGH"}, {"id": "M10054", "name": "Hypoglycemic Agents", "relevance": "LOW"}, {"id": "M27957", "name": "Dipeptidyl-Peptidase IV Inhibitors", "relevance": "LOW"}, {"id": "M19609", "name": "HIV Protease Inhibitors", "relevance": "LOW"}, {"id": "M14343", "name": "Protease Inhibitors", "relevance": "LOW"}, {"id": "M7951", "name": "Enzyme Inhibitors", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Hypo", "name": "Hypoglycemic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "Infe", "name": "Anti-Infective Agents"}]}}, "hasResults": true}